Financial Data and Key Metrics - Q4 revenue grew 26% YoY to 22.27 million, representing a 24% margin [19] - Non-GAAP EPS for Q4 was 332 million, a 62% increase from the end of 2022 [19] - Full-year 2023 revenue increased 20% to 61.9 million, representing a 19% margin [38] - ARR grew 27% YoY to 316 million for the full year [19][60] Business Line Performance - Subscription revenue accounted for 85% of total revenue in 2023, with perpetual license revenue declining 36% [152] - Cloud-based revenue grew rapidly in 2023, though it represented less than 10% of total revenue [12] - Pathfinder deals reached a record number in Q4, with approximately 200 agencies now using the solution [27] - Inseyets, a new solution, has seen strong interest, with upgrades contributing to a 65% ARR increase at one national police force [52] Market Performance - Americas accounted for 53% of total ARR in 2023, followed by EMEA at 36% and Asia-Pacific at 11% [36] - ARR growth in the Americas was 30%, EMEA grew 23%, and Asia-Pacific increased 29% [36] - A large deal with a Western European national police force grew ARR by more than 25% [22] Strategy and Industry Competition - The company is focusing on expanding its Case-to-Closure (C2C) platform, which integrates digital forensic and investigative tools [18][26] - Investments in cloud infrastructure and FedRAMP certification are expected to open up more federal opportunities [25] - The company plans to scale its SaaS offerings, including cloud-enabling previously on-prem solutions and developing cloud-native offerings [25] - Inseyets is positioned as a game-changer, enabling customers to complete examinations up to twice as fast as before [9] Management Commentary on Operating Environment and Future Outlook - The company expects Q1 2024 revenue to range between 88 million, representing 17% to 24% YoY growth [41] - Full-year 2024 revenue is expected to range from 385 million, with ARR targets between 400 million [153] - Adjusted EBITDA for 2024 is anticipated to be between 80 million, with margins of 19% to 21% [42] - The company is optimistic about improving profitability and expects higher adjusted EBITDA margins in the second half of 2024 [42] Other Important Information - The company plans to expand its workforce by approximately 15% in 2024, focusing on go-to-market and innovation initiatives [13] - FedRAMP certification is a key milestone expected to unlock additional federal opportunities [119][120] - The company is exploring inorganic growth opportunities, including technological tuck-ins and larger acquisitions [112] Q&A Summary Question: Inseyets Pricing and Productivity Impact - Inseyets is priced 20% to 25% higher than legacy solutions, with additional modules contributing to higher value [104] - The company expects Inseyets to drive significant growth, with upgrades and add-on modules contributing to ARR expansion [20][24] Question: Subscription Revenue Benchmark - Subscription revenue is expected to remain around 85% of total revenue, with perpetual licenses becoming negligible [81][142] Question: Pathfinder and Guardian Contribution - Pathfinder and Guardian are emerging growth engines, with Pathfinder deals growing significantly in Q4 [27][90] - Both solutions are expected to grow faster than the core Inseyets offering, contributing to ARR growth in 2024 [106] Question: FedRAMP Market Opportunity - FedRAMP certification is expected to double the company's federal business by enabling access to additional buying centers [132] Question: Training and Customer Adoption - Training is essential for customer adoption, especially in law enforcement, and is integrated into the company's post-sale customer experience strategy [78][89] Question: M&A Strategy - Inorganic growth is part of the company's long-term strategy, with potential targets being evaluated [112] Question: Competitive Pricing Dynamics - The company operates in a value-based market, with competitors also increasing prices systematically [115]
Cellebrite DI .(CLBT) - 2023 Q4 - Earnings Call Transcript